Yayın:
Changes in inflammatory mediators as a result of intermittent hypoxia in obstructive sleep apnea syndrome

dc.contributor.authorSozer, Volkan
dc.contributor.authorKutnu, Muge
dc.contributor.authorAtahan, Ersan
dc.contributor.authorOzturk, Buket Caliskaner
dc.contributor.authorHysi, Ergi
dc.contributor.authorCabuk, Cansu
dc.contributor.authorMusellim, Benan
dc.contributor.authorSimsek, Gonul
dc.contributor.authorUzun, Hafize
dc.date.accessioned2026-06-27T14:11:56Z
dc.date.issued2018
dc.description.abstractBackgroundInflammation plays an important role in obstructive sleep apnea syndrome (OSAS). The objective of this study was to investigate the relationship of serum C-reactive protein (CRP), pentraxin-3 (PTX-3), procalcitonin (ProCT), interleukin-33 (IL-33) and its soluble receptor ST2 (sST2) with the syndrome severity and to show theirs importance as biomarkers. MethodsThis study comprises a total of 84 identical (sex and age wise) cases. Full-night polysomnography was performed in each patient. OSAS diagnosis and severity index being based on the widely used criterion known as Apnea Hypopnea Index(AHI). Subgroups were as follows: 24(AHI 30). ResultsPTX-3, IL-33 and sST2 receptors were significantly higher in OSAS groups than the control group (P<.001). However, both CRP and ProCT levels were similar in all subjects. There was a positive correlation between PTX-3 and BMI (r=0.446; P<.01), ODI (r=0.555; P<.01), IL-33 (r=0.348; P=.001) and sST2 (r=326; P=.002), while there was a negative correlation with minimum SaO(2) (r=-0.672; P<.01) in patient group. PTX-3 as a predictor of OSAS showed highest specificity (%91.7) and sensitivity (%91.7) (P<.001). ConclusionsPTX-3 can be a new indicator reflecting the inflammatory state in patients with OSAS. Since patients with OSAS could have more hypoxic state during sleep, we found higher PTX-3 level in those patients and a negative correlation between PTX-3 and minimum SaO(2), which could explain that PTX-3 levels can increase with the severity of disease. Our results suggest that PTX-3 as an inflammatory biomarker may play a crucial role as an indicator of syndrome severity in OSAS.en
dc.description.sponsorshipIstanbul University [BYP-2016-21997]
dc.description.urihttps://doi.org/10.1111/crj.12718
dc.identifier.doi10.1111/crj.12718
dc.identifier.eissn1752-699X
dc.identifier.endpage1622
dc.identifier.issn1752-6981
dc.identifier.issue4
dc.identifier.pubmed28960823
dc.identifier.startpage1615
dc.identifier.urihttps://hdl.handle.net/20.500.14981/57846
dc.identifier.volume12
dc.identifier.wos000429581600036
dc.language.isoeng
dc.publisherWILEY
dc.relation.ispartofCLINICAL RESPIRATORY JOURNAL
dc.subjectinterleukin-33
dc.subjectinflammation
dc.subjectintermittent hypoxia
dc.subjectobstructive sleep apnea syndrome
dc.subjectprocalcitonin
dc.subjectpentraxin-3
dc.subjectC-REACTIVE PROTEIN
dc.subjectSYSTEMIC INFLAMMATION
dc.subjectASSOCIATION
dc.subjectMARKERS
dc.subjectEVENTS
dc.subjectRISK
dc.subjectRespiratory System
dc.titleChanges in inflammatory mediators as a result of intermittent hypoxia in obstructive sleep apnea syndrome
dc.typeArticle
dspace.entity.typePublication
local.import.sourceWOS

Dosyalar

Koleksiyonlar